en

PRODUCT DETAIL

Tysabri 150 mg injekčný roztok v naplnenej injekčnej striekačke

Code 7495D
MA number EU/1/06/346/002
Product Form: sol inj 2x1 ml/150 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA23 Natalizumab
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 27.06.2006
SmPC + PL: European Medicines Agency's database
Dokument: DHPC Tysabri 18 3 2016.pdf  
Dokument: DHPC Tysabri_DHPC 24 3 2010.pdf  
Safety feature Yes
Data update: 27.05.2021
eu-flag.png sk-flag.png